Allbirds Review – Buy Shoes, Not Gift Cards

Allbirds makes merino wool and eucalyptus-fibre shoes, priced around $100 for most models. The shoes themselves are a real product with a genuine material story. The company’s position is the thing you should know first: its own annual report states “there is substantial doubt about our ability to continue as a going concern”, revenue fell 19.7% last year, and on the day we checked only 18% of the catalogue was in stock. Buy the shoes if they fit. Do not buy a gift card.

Read the Filing First

This is a publicly traded company, which means we do not have to speculate about its health — it is obliged to tell us. From the Form 10-K for the year ended 31 December 2025, filed 31 March 2026:

The filing attributes the revenue fall to a $23.1 million decline in the US direct business “resulting from store closures” and $11.9 million internationally “due to our transition to third-party distributors”. It also discloses a 1-for-20 reverse stock split effective 4 September 2024, undertaken after the shares traded below Nasdaq’s minimum bid price for 30 consecutive days, and continuing delisting risk.

82% of the Catalogue Is Unavailable

We pulled the full product feed and counted. Across 291 products and 2,829 variants — a variant being a specific size and colour — 505 were in stock.

In practice this is what a shopper actually experiences: the model you want in the colour you want, but not your size — or your size in one colourway only. It is consistent with a business managing inventory tightly under financial pressure, and it is the most immediate practical consequence of everything in the section above.

The practical advice: if you find your size in a shoe you like, that is the moment to buy it. Do not assume it will still be there next month, and do not build a plan around restocks.

The Parent Company Changed Its Name

One more fact from the public record, which we report carefully because we do not know what it means.

The SEC filing record for this registrant lists the name “Allbirds, Inc.” running to 15 June 2026. After that date the registrant appears as “Smartbird, Inc.” The ticker remains BIRD, and the consumer-facing brand and website remain Allbirds.

We are not going to interpret that for you. Corporate renames happen for many reasons — a holding-company restructure, a plan to operate several brands, a rebranding exercise — and we found no explanation we could verify. What we can say is that a company renaming itself away from its flagship brand, two months after filing a going-concern disclosure, is a fact worth knowing before you spend $100. Read it as context, not as a prediction.

Prices, and a Catalogue-Wide Sale

The low end of that range is socks and small accessories; the shoes sit mostly at and above $100. That is mid-market for footwear — well below premium running brands’ flagship models, above supermarket shoes.

On the discounting: when 57% of a catalogue carries a struck-through price at a median 40% off, the crossed-out number is functioning as a reference price rather than a deal you have caught. That said, in this particular case the discounting is also plainly what it looks like — a business with falling revenue clearing inventory. If you want the shoes, the prices are genuinely lower than they were; just do not treat the “was” figure as a deadline.

What Shoes Can and Cannot Do

Footwear is sold on injury prevention — pronation control, stability, cushioning, gait analysis at the shop counter. It is worth knowing what the randomised evidence says about all that, because it is not what the industry implies, and because it changes how you should choose.

A separate systematic review in the British Journal of Sports Medicine covering 30 randomised trials on running knee injuries found that “various footwear options… did not influence knee injury risk” (risk ratios 0.55 to 1.06) — while running technique retraining to land more softly reduced knee injury risk by roughly two-thirds (RR 0.32, 95% CI 0.16 to 0.63) on low-certainty evidence from one trial of 320 participants.

Why This Is on a Weight-Loss Site

Because walking is the exercise people actually keep doing, and the single biggest determinant of whether you keep doing it is whether it is pleasant. PubMed indexes 562 randomised controlled trials on walking and physical activity adherence and 311 on walking and weight loss. It is not a fringe intervention; it is the default one.

Against that background, a comfortable everyday shoe is a genuinely sensible purchase for someone trying to move more — more so than a technical running shoe they will wear twice. The honest version of the pitch is not “these shoes will improve your health”; it is “shoes you find comfortable enough to walk in are worth having, and the brand matters far less than the fit”.

The Sustainability Claims

Sustainability is the brand’s founding proposition, so we counted how it actually appears in the product copy across all 291 descriptions.

The material claims are specific and substantive. Merino wool and eucalyptus tree fibre are real, identifiable materials, and a shoe made of them is genuinely different from a synthetic one — this is not a conventional trainer with a green sticker. That is the honest core of the brand and it holds up.

The carbon labelling is the part we could not find. Allbirds became known for printing a carbon footprint figure on its products, and across every product description we retrieved the word “carbon” appeared just four times, with “CO2e” not appearing at all. We read the catalogue feed, not the rendered product pages, so the figure may well live in a page element we did not see. Treat this as we did not find it rather than it has gone — but if the carbon number is why you are buying, check it is still there.

Two things do check out in the filings. The company describes itself as “a Delaware public benefit corporation, or PBC, and certified B Corporation, or B Corp” — and, tellingly, lists as a risk that its board’s “duty to balance various interests and our public benefit purpose may result in actions that do not maximize stockholder value”. It also warns investors that its “focus on using sustainable, high-quality materials… may increase our cost of revenue and hinder our revenue growth”. Those are commitments with a cost attached, disclosed to shareholders. That is a meaningfully stronger signal than a marketing page.

How to Buy From a Company in This Position

This is the practical heart of the review. A going-concern disclosure does not mean do not buy — it means buy differently.

None of that is alarmist. It is the same checklist we would give for any retailer carrying this disclosure, and it costs you nothing to follow.

Eligibility and Availability

Availability: the affiliate programme is registered for the United States only, and we make no claim about other markets. Note from the filing that the international business has been transitioned “to third-party distributors”, so the buying experience outside the US may differ substantially from the US direct one.

No membership, subscription or auto-renewal is involved — it is a shop. We were not able to read the returns policy from the pages we retrieved, so we are not stating a return window, a free-returns claim or a warranty length. Check those on the site before ordering, and check them more carefully than you normally would.

Legitimacy and Credentials

It is worth saying clearly: everything critical in this review comes from the company itself. Allbirds disclosed its own going-concern doubt, its own revenue decline, its own store closures and its own delisting risk, because a public company must. That transparency is the reason you can make an informed decision here at all — which is more than can be said for most of the private brands we review.

How It Compares

Who Should Buy, and Who Should Look Elsewhere

Buy a pair if:

• You have worn Allbirds before and know they suit your feet — that removes the fit risk entirely
• You find your size in stock and the discounted price is right
• You want merino or eucalyptus specifically. Few brands offer them at this price
• You are buying a comfortable everyday shoe to walk more in, which is a sound reason
• You will pay by card and treat it as a one-off purchase rather than a relationship

Look elsewhere if:

• You were going to buy a gift card. Buy the shoes instead
• You need a specific size and colour reliably — at 18% availability, you may not get it
• You are relying on long-term warranty or aftercare
• You have diabetes with neuropathy and need clinically appropriate footwear. See a podiatrist
• You are buying for the carbon label specifically and cannot confirm it is still published
• You want to try before you buy but have no store within reach

Pros and Cons

Limitations of This Review

Checked on 11 August 2026 against the allbirds.com product feed (291 products, 2,829 variants), the company’s Form 10-K for the year ended 31 December 2025 and its SEC filing record, the Cochrane Library and PubMed. Stock and prices change daily; the availability figure is a single-day snapshot and will not match what you see.

We did not wear the shoes. Nothing was bought, worn or walked in. We cannot tell you how they fit, how they wear, whether the wool holds up, how they handle rain, or whether sizing runs true — which for footwear is most of what you want to know. This review covers company condition, stock, pricing, claims and the published evidence on footwear generally.

Several things we could not retrieve and have therefore not stated: the returns policy and window, warranty terms, shipping costs and thresholds, current store count, and any Trustpilot or BBB record. On the carbon labelling, we read the catalogue feed rather than the rendered pages, so its absence from our data is not evidence of its absence from the site. On the corporate rename, we report the dated fact from the SEC record and explicitly decline to interpret it.

On the financial disclosure: the figures are from a filing dated 31 March 2026 and are several months old. A going-concern disclosure describes management’s assessment at that date; it is not a prediction, and companies routinely trade through it. Nothing here is financial advice, and nothing here is a claim that the company will or will not continue.

On the footwear evidence: the Cochrane review concerns running injuries in adults, mostly over 6 to 26 weeks, with much of the evidence rated low or very low certainty, and three of the foot-type trials used military populations. It says shoe type has not been shown to change injury rates — not that shoes are irrelevant, and not that any particular shoe is good or bad. None of this is medical advice; foot pain, and footwear for anyone with diabetes, belong with a clinician.

Frequently Asked Questions

Verdict

The rating is about the purchase, not the product. On the shoes themselves there is a lot to like. Merino wool and eucalyptus fibre are real, distinguishable materials rather than a green sticker on a synthetic trainer. The brand sells comfort rather than pronation control and gait correction — and a Cochrane review of 12 trials and 11,240 participants found no shoe type reduces running injuries, with the strongest finding in the whole review being that prescribing shoes by foot type does not work. Allbirds is, almost accidentally, selling shoes on the only basis the evidence supports.

And the sustainability commitment is more than a marketing page. A Delaware public benefit corporation and certified B Corp that tells investors its board may take “actions that do not maximize stockholder value” and that sustainable materials “may increase our cost of revenue” has attached a real price to the position.

What you have to weigh against that comes from the company’s own annual report. “There is substantial doubt about our ability to continue as a going concern.” Revenue down 19.7% to $152.5 million. A net loss of $77.3 million on top of $93.3 million the year before. Store closures named as the reason US sales fell. A 1-for-20 reverse stock split to stay listed. A registrant that stopped being called Allbirds, Inc. on 15 June 2026. And, on the shelf right now, 505 of 2,829 variants in stock.

So the advice is narrow and practical rather than a yes or a no. If you find a pair you like in your size at a discounted price, buy them, pay by card, and enjoy them. Do not buy a gift card. Do not sit on store credit. Do not buy on the strength of future aftercare. And if you are buying shoes because you want to walk more — which is the best reason on this page — remember that the brand matters far less than whether they are comfortable enough that you actually put them on.